Correlation Between Abcellera Biologics and BCE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and BCE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and BCE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and BCE Inc, you can compare the effects of market volatilities on Abcellera Biologics and BCE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of BCE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and BCE.

Diversification Opportunities for Abcellera Biologics and BCE

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Abcellera and BCE is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and BCE Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BCE Inc and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with BCE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BCE Inc has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and BCE go up and down completely randomly.

Pair Corralation between Abcellera Biologics and BCE

Given the investment horizon of 90 days Abcellera Biologics is expected to generate 4.62 times more return on investment than BCE. However, Abcellera Biologics is 4.62 times more volatile than BCE Inc. It trades about 0.07 of its potential returns per unit of risk. BCE Inc is currently generating about -0.32 per unit of risk. If you would invest  289.00  in Abcellera Biologics on September 4, 2024 and sell it today you would earn a total of  14.00  from holding Abcellera Biologics or generate 4.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Abcellera Biologics  vs.  BCE Inc

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
BCE Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BCE Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Abcellera Biologics and BCE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and BCE

The main advantage of trading using opposite Abcellera Biologics and BCE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, BCE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCE will offset losses from the drop in BCE's long position.
The idea behind Abcellera Biologics and BCE Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments